Ballicules.com

Alprazolam XR

XANAX XR

What it isExtended-release GABA-A positive allosteric modulator (XANAX XR, 2003); panic disorder.

Why this oneSmoother exposure reduces interdose rebound compared with immediate-release alprazolam.

What limits itDependence develops quickly and abrupt withdrawal can cause seizures. Opioids magnify respiratory depression; CYP3A4 interactions matter.

FDA-approved for

FDA label

BOXED WARNING Concomitant use with opioids; abuse, misuse, and addiction; dependence and withdrawal reactions
FDA dosingPopulationStartTargetMax
Panic disorder (with or without agoraphobia)Adults0.5–1 mg QD (AM)3–6 mg QD10 mg QD

Titration Adjust at intervals of 3–4 days in increments of ≤1 mg/day

Renal Undefined

Hepatic Start 0.5 mg once daily; increase gradually if tolerated

Geriatric: start 0.5 mg once daily; reduce dose with ritonavir

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Neonatal sedation/withdrawal with late-pregnancy use; no clear major-defect association

Lactation Present in breast milk; breastfeeding not recommended during treatment

⚠ BOXED WARNINGS

Classes and tags

Clinical profile

Direct muscarinic antagonism0 / 4

Active metabolites

Mechanism of action: Alprazolam XR ballicule

Alprazolam XR ballicule: receptor binding, kinetics and half-life diagram

Open Alprazolam XR in the interactive console ↗

Memory aids: mascots and interaction avatars

Alprazolam XR XANAX mascot mnemonic cartoon
“Lil’ Xan, Alp-raised lamb”
No fear → benzos are anxiolytic drugs
Pill bottle → symbol for benzodiazepine class
Alprazolam XR CYP3A4 substrate avatar
CYP3A4 substrate

Open Alprazolam XR in the interactive console ↗